The increase in the population of DN T cells in PBMCs from SLE patients finds validation from earlier reports of high levels of DN T cells in SLE patients being associated with disease severity [1] and also that the increased DN T cells act as a source of inflammatory IL-17 seen upregulated in SLE patients [11]. This evidence concerns the gene IL17A and systemic lupus erythematosus.